MedTrace Logo

Dual-wave Boluses in Children With Type 1 Diabetes Insulin Boluses in Children With Type 1 Diabetes

NCT04668612 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-04-01

No results posted yet for this study

Summary

To analyze with the aid of CGM the blood sugar profiles of children receiving dual-wave versus standard bolus for dinner.

Conditions

Interventions

DEVICE

Dual-bolus

Dual-bolus (50/50% with second part over 2 hours) for all meals after 6:00 p.m.

DEVICE

Standard bolus

Standard boluses for all meals

Sponsors & Collaborators

  • Estonian Research Council

    collaborator UNKNOWN

  • Tartu University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
7 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-04
Primary Completion
2021-05-20
Completion
2021-06-30
FDA Device
Yes

Countries

  • Estonia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04668612 on ClinicalTrials.gov